Minimal Residual Disease Status, Outcomes in Patients with Multiple Myeloma
A new study examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes.
A new study examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes.
Leave a Reply